Showing results (41-50 of 248) with videos related to
Sort By:
Pageof 25
Leukemia & Lymphoma|September 18, 2024
Vaccination strategies for patients with lymphoma treated in early lines of therapies: a real-world practice survey among Fondazione Italiana Linfomi centersOmbretta Annibali, Michele Merli, Carla Minoia, et al.Expert Review of Hematology|June 5, 2018
Diagnosis and management of prefibrotic myelofibrosisElisa Rumi, Emanuela Sant'Antonio, Emanuela Boveri, et al.International Journal of Molecular Sciences|April 12, 2019
The Possible Role of Gut Microbiota and Microbial Translocation Profiling During Chemo-Free Treatment of Lymphoid MalignanciesValentina Zuccaro, Andrea Lombardi, Erika Asperges, et al.Haematologica|June 1, 2010
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphomaSilvia Zibellini, Daniela Capello, Francesco Forconi, et al.Journal of Internal Medicine|November 26, 2025
Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and managementAnna Linda Zignego, Laura Gragnani, Marcella Visentini, et al.American Journal of Hematology|August 6, 2019
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) networkMarzia Varettoni, Emanuela Boveri, Silvia Zibellini, et al.Haematologica|November 9, 2014
The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infectionLuca Arcaini, Davide Rossi, Marco Lucioni, et al.American Journal of Hematology|August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapiesMarzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana LinfomiMichele Merli, Sara Rattotti, Michele Spina, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-upErcole Brusamolino, Ambrogia Baio, Ester Orlandi, et al.Pageof 25